FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DCPS-CCND1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DCPS-CCND1
FusionPDB ID: 21655
FusionGDB2.0 ID: 21655
HgeneTgene
Gene symbol

DCPS

CCND1

Gene ID

28960

595

Gene namedecapping enzyme, scavengercyclin D1
SynonymsARS|DCS1|HINT-5|HINT5|HSL1|HSPC015BCL1|D11S287E|PRAD1|U21B31
Cytomap

11q24.2

11q13.3

Type of geneprotein-codingprotein-coding
Descriptionm7GpppX diphosphatase5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatasedecapping scavenger enzymeepididymis secretory sperm binding proteinheat shock-like protein 1hint-related 7meGMP-directed hydrolasehistidine triad nucleotide-binding prG1/S-specific cyclin-D1B-cell CLL/lymphoma 1B-cell lymphoma 1 proteinBCL-1 oncogenePRAD1 oncogene
Modification date2020031320200327
UniProtAcc

Q96C86

Main function of 5'-partner protein: FUNCTION: Decapping scavenger enzyme that catalyzes the cleavage of a residual cap structure following the degradation of mRNAs by the 3'->5' exosome-mediated mRNA decay pathway. Hydrolyzes cap analog structures like 7-methylguanosine nucleoside triphosphate (m7GpppG) with up to 10 nucleotide substrates (small capped oligoribonucleotides) and specifically releases 5'-phosphorylated RNA fragments and 7-methylguanosine monophosphate (m7GMP). Cleaves cap analog structures like tri-methyl guanosine nucleoside triphosphate (m3(2,2,7)GpppG) with very poor efficiency. Does not hydrolyze unmethylated cap analog (GpppG) and shows no decapping activity on intact m7GpppG-capped mRNA molecules longer than 25 nucleotides. Does not hydrolyze 7-methylguanosine diphosphate (m7GDP) to m7GMP (PubMed:22985415). May also play a role in the 5'->3 mRNA decay pathway; m7GDP, the downstream product released by the 5'->3' mRNA mediated decapping activity, may be also converted by DCPS to m7GMP (PubMed:14523240). Binds to m7GpppG and strongly to m7GDP. Plays a role in first intron splicing of pre-mRNAs. Inhibits activation-induced cell death. {ECO:0000269|PubMed:11747811, ECO:0000269|PubMed:12198172, ECO:0000269|PubMed:12871939, ECO:0000269|PubMed:14523240, ECO:0000269|PubMed:15273322, ECO:0000269|PubMed:15383679, ECO:0000269|PubMed:15769464, ECO:0000269|PubMed:16140270, ECO:0000269|PubMed:18426921, ECO:0000269|PubMed:22985415}.

P24385

Main function of 5'-partner protein: FUNCTION: Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. Exhibits transcriptional corepressor activity with INSM1 on the NEUROD1 and INS promoters in a cell cycle-independent manner. {ECO:0000269|PubMed:15241418, ECO:0000269|PubMed:16569215, ECO:0000269|PubMed:18417529, ECO:0000269|PubMed:9106657}.
Ensembl transtripts involved in fusion geneENST idsENST00000263579, ENST00000530860, 
ENST00000536559, ENST00000227507, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score5 X 3 X 3=4515 X 16 X 5=1200
# samples 516
** MAII scorelog2(5/45*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(16/1200*10)=-2.90689059560852
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: DCPS [Title/Abstract] AND CCND1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DCPS [Title/Abstract] AND CCND1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DCPS(126176639)-CCND1(69462761), # samples:2
Anticipated loss of major functional domain due to fusion event.DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a cell metabolism gene due to the frame-shifted ORF.
DCPS-CCND1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
DCPS-CCND1 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
DCPS-CCND1 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneDCPS

GO:0036245

cellular response to menadione

16140270

HgeneDCPS

GO:0043069

negative regulation of programmed cell death

16140270

HgeneDCPS

GO:0045292

mRNA cis splicing, via spliceosome

18426921

TgeneCCND1

GO:0000082

G1/S transition of mitotic cell cycle

19412162

TgeneCCND1

GO:0000122

negative regulation of transcription by RNA polymerase II

16569215|18417529

TgeneCCND1

GO:0001934

positive regulation of protein phosphorylation

8114739

TgeneCCND1

GO:0006974

cellular response to DNA damage stimulus

19412162

TgeneCCND1

GO:0010971

positive regulation of G2/M transition of mitotic cell cycle

19124461

TgeneCCND1

GO:0031571

mitotic G1 DNA damage checkpoint

19412162

TgeneCCND1

GO:0044321

response to leptin

17344214

TgeneCCND1

GO:0045737

positive regulation of cyclin-dependent protein serine/threonine kinase activity

8114739

TgeneCCND1

GO:0070141

response to UV-A

18483258

TgeneCCND1

GO:0071157

negative regulation of cell cycle arrest

19124461



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:126176639/chr11:69462761)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DCPS (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CCND1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000263579DCPSchr11126176639+ENST00000227507CCND1chr1169462762+42117051071018303
ENST00000263579DCPSchr11126176639+ENST00000227507CCND1chr1169462761+42117051071018303

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000263579ENST00000227507DCPSchr11126176639+CCND1chr1169462762+0.0002550260.99974495
ENST00000263579ENST00000227507DCPSchr11126176639+CCND1chr1169462761+0.0002550260.99974495

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DCPS-CCND1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DCPSchr11126176639CCND1chr1169462761705199YSTYHLFPPRQLNDVKFISNPPSMVA
DCPSchr11126176639CCND1chr1169462762705199YSTYHLFPPRQLNDVKFISNPPSMVA

Top

Potential FusionNeoAntigen Information of DCPS-CCND1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DCPS-CCND1_126176639_69462761.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DCPS-CCND1chr11126176639chr1169462761705HLA-B13:01RQLNDVKFI0.69020.7151918
DCPS-CCND1chr11126176639chr1169462761705HLA-B52:01RQLNDVKFI0.01390.7259918
DCPS-CCND1chr11126176639chr1169462761705HLA-B48:02RQLNDVKF0.86890.7624917
DCPS-CCND1chr11126176639chr1169462761705HLA-A02:03HLFPPRQLNDV0.9960.6761415

Top

Potential FusionNeoAntigen Information of DCPS-CCND1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DCPS-CCND1_126176639_69462761.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DCPS-CCND1chr11126176639chr1169462761705DRB1-0103YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-0103STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-0109YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-0115YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-0115STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-0338LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0403LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0403QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0403RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0413LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0413QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0413RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0415LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0415QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0419LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0427LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0427QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0427RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0431LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0436LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0436QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0437LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0437QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0439LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0439QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0439RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0440LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0440QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0440RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0441LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0441QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0441RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0442LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0442QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0442RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0443LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0444LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0444QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0444RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0446LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0446QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0446RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0449LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0449QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0449RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0450LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0450QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0450RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0451LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0451QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0451RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0452LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0452QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0452RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0453LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0453QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0455LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0455QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0455RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0456LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0456QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0456RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0458LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0458QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0459LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0459QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0459RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0460LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0460QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0460RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0461LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0465LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0465QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0468LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0468QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0468RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0470LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0470QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0470RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0471LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0471QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0471RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0473LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0473QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0475LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0478LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0478QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0479LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0479QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0479RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0485LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0485QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0485RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-0488LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-0488QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB1-0488RQLNDVKFISNPPSM924
DCPS-CCND1chr11126176639chr1169462761705DRB1-1419LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1446LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1447LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1448LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1493LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1502YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1502STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1508YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1508STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1511YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1511STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1514YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1514STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1515YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1515STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1519YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1519STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1526YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1526STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1527YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1529YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1529STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1530YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1530STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1531YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1531STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1534YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1538YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1538STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1539YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1539STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1544YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1544STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1547YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1547STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1601YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1602YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1603YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1604YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1604STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1605YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1607YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1608YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1609YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1609STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1610YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1610STYHLFPPRQLNDVK116
DCPS-CCND1chr11126176639chr1169462761705DRB1-1611YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1612YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1614YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB1-1615LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB1-1616YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB3-0109LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0201LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0202LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0204LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0205LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0209LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0209QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB3-0210LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0211LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0212LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0213LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0214LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0215LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0216LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0216QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB3-0217LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0218LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0219LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0219QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB3-0220LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0221LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0221QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB3-0222LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0222QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB3-0223LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0224LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0225LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0303LNDVKFISNPPSMVA1126
DCPS-CCND1chr11126176639chr1169462761705DRB3-0303QLNDVKFISNPPSMV1025
DCPS-CCND1chr11126176639chr1169462761705DRB5-0102YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB5-0103YSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB5-0108NYSTYHLFPPRQLNDV015
DCPS-CCND1chr11126176639chr1169462761705DRB5-0203YSTYHLFPPRQLNDV015

Top

Fusion breakpoint peptide structures of DCPS-CCND1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
2506FPPRQLNDVKFISNDCPSCCND1chr11126176639chr1169462761705

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DCPS-CCND1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN2506FPPRQLNDVKFISN-7.9962-8.1096
HLA-B14:023BVN2506FPPRQLNDVKFISN-5.70842-6.74372
HLA-B52:013W392506FPPRQLNDVKFISN-6.83737-6.95077
HLA-B52:013W392506FPPRQLNDVKFISN-4.4836-5.5189
HLA-A11:014UQ22506FPPRQLNDVKFISN-10.0067-10.1201
HLA-A11:014UQ22506FPPRQLNDVKFISN-9.03915-10.0745
HLA-A24:025HGA2506FPPRQLNDVKFISN-6.56204-6.67544
HLA-A24:025HGA2506FPPRQLNDVKFISN-5.42271-6.45801
HLA-B44:053DX82506FPPRQLNDVKFISN-7.85648-8.89178
HLA-B44:053DX82506FPPRQLNDVKFISN-5.3978-5.5112
HLA-A02:016TDR2506FPPRQLNDVKFISN-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of DCPS-CCND1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DCPS-CCND1chr11126176639chr1169462761415HLFPPRQLNDVACTTGTTCCCTCCAAGACAACTGAATGATGTGA
DCPS-CCND1chr11126176639chr1169462761917RQLNDVKFGACAACTGAATGATGTGAAGTTCA
DCPS-CCND1chr11126176639chr1169462761918RQLNDVKFIGACAACTGAATGATGTGAAGTTCATTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DCPS-CCND1chr11126176639chr1169462761015YSTYHLFPPRQLNDVACAGCACCTATCACTTGTTCCCTCCAAGACAACTGAATGATGTGA
DCPS-CCND1chr11126176639chr1169462761116STYHLFPPRQLNDVKGCACCTATCACTTGTTCCCTCCAAGACAACTGAATGATGTGAAGT
DCPS-CCND1chr11126176639chr11694627611025QLNDVKFISNPPSMVAACTGAATGATGTGAAGTTCATTTCCAATCCGCCCTCCATGGTGG
DCPS-CCND1chr11126176639chr11694627611126LNDVKFISNPPSMVATGAATGATGTGAAGTTCATTTCCAATCCGCCCTCCATGGTGGCAG
DCPS-CCND1chr11126176639chr1169462761924RQLNDVKFISNPPSMGACAACTGAATGATGTGAAGTTCATTTCCAATCCGCCCTCCATGG

Top

Information of the samples that have these potential fusion neoantigens of DCPS-CCND1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
ESCADCPS-CCND1chr11126176639ENST00000263579chr1169462761ENST00000227507TCGA-IG-A3I8

Top

Potential target of CAR-T therapy development for DCPS-CCND1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DCPS-CCND1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DCPS-CCND1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource